|
|
The Actavis Group is represented in Poland by the following two entities:
• Actavis Polska – marketing and promotion
• Biovena Pharma – production and distribution
The Actavis Group has a wide portfolio of modern pharmaceuticals, which are used mainly in the treatment of urological, psychiatric, neurological, cardiological, dermatological, laryngological, muscular-skeletal and oncological diseases.
27 products are marketed and 15 new product launches are planned for 2008 on the Polish market.
In total, more than 170 people are working for the Actavis Group in Poland.
Contact information:
Actavis Polska Sp. z o.o.
Warszawa 03-310
ul. Odrowaza 15
Poland
Tel.: +48 22 8141239
Fax.: +48 22 8141241
Managing Director: Robert Czernik
E-mail: biuro@actavis.com
www.actavispolska.pl
Biovena Pharma Sp. z o.o.
Warszawa 03-310
ul. Odrowaza 13
Poland
Tel.: +48 22 8141239
Fax.: +48 22 8141241
E-mail: biuro@actavis.com |